Abstract | BACKGROUND: STUDY DESIGN: We searched the PubMed database for peer-reviewed articles that were published in any language from inception of the database through January 2012 and were relevant to therapeutic or prophylactic treatments for unscheduled uterine bleeding during extended or continuous combined hormonal contraception use. We used standard abstract forms and grading systems to summarize and assess the quality of the evidence. RESULTS: Four articles met the inclusion criteria. Evidence from two randomized controlled trials, both of fair quality, suggested that a short hormone-free interval of 3 or 4 days improved a current unscheduled bleeding episode. Evidence from one randomized controlled trial of fair quality suggested that oral doxycycline (100 mg twice daily) did not improve a current unscheduled bleeding episode. One good quality randomized controlled trial suggested that prophylactic treatment with a daily low dose of oral doxycycline (40 mg) caused earlier onset of amenorrhea in new extended combined oral contraceptive users. CONCLUSIONS: Limited evidence suggests that introducing a short hormone-free interval when unscheduled bleeding occurs during continuous or extended hormonal contraceptive use may reduce unscheduled bleeding days; one study suggests that twice-daily oral doxycycline initiated at the time of unscheduled bleeding is an ineffective treatment. Limited data suggest that prophylactic low-dose daily oral doxycycline may induce earlier amenorrhea among new extended combined hormonal contraceptive users.
|
Authors | Emily M Godfrey, Maura K Whiteman, Kathryn M Curtis |
Journal | Contraception
(Contraception)
Vol. 87
Issue 5
Pg. 567-75
(May 2013)
ISSN: 1879-0518 [Electronic] United States |
PMID | 23044386
(Publication Type: Journal Article, Review, Systematic Review)
|
Copyright | Copyright © 2013 Elsevier Inc. All rights reserved. |
Chemical References |
- Contraceptives, Oral, Combined
|
Topics |
- Contraceptive Devices, Female
(adverse effects)
- Contraceptives, Oral, Combined
(administration & dosage, adverse effects)
- Female
- Humans
- Menstruation Disturbances
(chemically induced, therapy)
- Metrorrhagia
(chemically induced, prevention & control, therapy)
- Randomized Controlled Trials as Topic
|